Edralin, Roselyn .

HRN: 24-08-74  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/16/2023
CEFUROXIME 1.5GM (VIAL)
11/16/2023
11/22/2023
IV
1.5 G
Q8
S/P CS
Checking Final Appropriateness 

 Indication:  Prophylaxis    Type of Infection:  Reproductive Tract    Compliance to guidelines: Compliant To Guidelines